Design, Pharmacokinetic and Pharmacodynamic Evaluation of Nanocarriers for Raloxifene Hydrochloride in the EffectiveTreatment of Post-menopausal Osteoporosis
JavaScript is disabled for your browser. Some features of this site may not work without it.
Design, Pharmacokinetic and Pharmacodynamic Evaluation of Nanocarriers for Raloxifene Hydrochloride in the EffectiveTreatment of Post-menopausal Osteoporosis